From Prediction to Intervention
Why healthcare quality AI must identify who will benefit—not just who is at risk.
Download the Research Briefing (PDF)High risk and high benefit are different questions
Healthcare quality programs often use predictive models to identify people most likely to experience an adverse outcome. That can be useful for prognosis and prioritization. It does not automatically establish who is most likely to benefit from a particular intervention.
Outcome risk
Who is most likely to experience the outcome without additional action?
Intervention benefit
Whose outcome is most likely to change because of this specific intervention?
Clinical utility
Does model-guided allocation improve decisions, workflow, safety, equity, and outcomes in practice?
What this briefing helps leaders evaluate
- Why conventional risk prediction and individualized intervention-benefit estimation answer different questions.
- When risk ranking may be useful—and when it may not be enough for allocating a scarce intervention.
- Why benefit-model validation must match the vendor or internal-team claim.
- How clinical utility, implementation capacity, equity, and patient preference affect allocation decisions.
- Which evidence limitations must remain visible, including the absence of a contemporary Medicare Advantage head-to-head comparison proving benefit-based targeting superior to risk ranking.
The QII position
The next stage of healthcare quality AI should be defined by a disciplined match between the decision being made and the evidence supporting it. Risk prediction is appropriate when the task is prognosis. Intervention allocation requires additional reasoning about modifiability, expected benefit, feasibility, clinical utility, and competing objectives.
Who should use it
This briefing is designed for health-plan, population-health, quality, clinical-informatics, analytics, care-management, Medicare Advantage, and value-based-care leaders deciding how predictive intelligence should guide real-world intervention.